What is it for?

Tirzepatide is the dual-agonist that outperformed semaglutide head-to-head. By hitting both GIP and GLP-1 receptors simultaneously, it delivers metabolic effects that single-mechanism peptides simply can't match. The SURMOUNT trials showed up to 22.5% body weight reduction — the highest numbers ever recorded in a weight management clinical program. Beyond the scale, tirzepatide improves insulin sensitivity, cleans up lipid panels, and shows early cardiovascular benefit signals. If semaglutide opened the door, tirzepatide kicked it wide open.

💉 Dosing Protocol

Start at 2.5mg weekly subcutaneous for 4 weeks. Escalate by 2.5mg every 4 weeks as tolerated, up to 10–15mg weekly. Slower titration reduces GI side effects significantly.

💡 Why dual agonism matters

GIP receptor activation amplifies everything GLP-1 does on appetite, and adds its own independent effects on fat oxidation and insulin sensitivity. Two pathways working together produce results neither achieves alone.

📦 Product Details

• Storage: Keep lyophilized vials frozen or at 2–8°C. After reconstitution, refrigerate and use within 4–6 weeks.
• Specs: Lyophilized powder, ≥98% purity (HPLC verified). Each order contains 10 vials.